Moderating Effects and Maintenance of Lung Cancer Cellular Immune Functions by CIK Cell Therapy

Jin, Cong-Guo; Chen, Xiao-Qun; Li, Jia; Wu, Zhi-Pin; Liu, Xin; Wang, Xi-Cai

추천

검색

자료유형: 학술저널

저자정보: Jin, Cong-Guo (Cancer Research Institute of Yunnan Cancer Hospital [The 3rd Affiliated Hospital of Kunming Medical University]) Chen, Xiao-Qun (Cancer Research Institute of Yunnan Cancer Hospital [The 3rd Affiliated Hospital of Kunming Medical University]) Li, Jia (Cancer Research Institute of Yunnan Cancer Hospital [The 3rd Affiliated Hospital of Kunming Medical University]) Wu, Zhi-Pin (Cancer Research Institute of Yunnan Cancer Hospital [The 3rd Affiliated Hospital of Kunming Medical University]) Liu, Xin (Cancer Research Institute of Yunnan Cancer Hospital [The 3rd Affiliated Hospital of Kunming Medical University]) Wang, Xi-Cai (Cancer Research Institute of Yunnan Cancer Hospital [The 3rd Affiliated Hospital of Kunming Medical University])

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제6호

발행연도: 2013.1

수록면: 3,587 - 3,592 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Aims: To study the CIK cell treatment effects on regulation of cellular immune function disorders in patients with lung cancer, and to analyze the time characteristics. Methods: Cellular immune function was assessed by FCM, and patients with functional disorders were randomly divided into two groups, one given CIK cell therapy within 18 months (5 courses) and the other the controls, which were followed up for 1 year with cellular immune functions tested once a month. Results: There were 5 types of cellular immunity, 4 of which are disorders; after CIK treatment, the improvement rate of the 4 groups were 79.1%, 70.8%, 76.0% and 70.0%, intergroup differences not being statistically significant (P=0.675), all significantly higher than in the control group (P=0.000). The median maintenance times for the 4 groups were 10.4 months (9.76-11.04), 8.4 months (7.86-8.94), 9.8 months (9.20-10.4) and 7.9 months (6.25-9.55), respectively. Conclusions: CIK cells were able to improve the immune functions of patients with lung cancer, the rate of improvement and maintenance time being related to the immune function before the treatment and CIK-cell-therapy courses.

#CIK cells #lung cancer #cellular immune disorders #improvement rate #maintenance time

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Jin, Cong-Guo

소속기관 Cancer Research Institute of Yunnan Cancer Hospital [The 3rd Affiliated Hospital of Kunming Medical